NewsWarning issued by WHO: Fake Ozempic drugs sold online

Warning issued by WHO: Fake Ozempic drugs sold online

According to the World Health Organization (WHO), counterfeit versions of a drug used to treat diabetes and obesity are being offered on the internet. These medications could be harmful to health. The original drug is available by prescription, but due to its growing popularity, it is often counterfeited.

WHO warns: Diabetes and weight loss medications are increasingly counterfeited
WHO warns: Diabetes and weight loss medications are increasingly counterfeited
Images source: © Pixabay

6:59 AM EDT, June 25, 2024

The drug's brand name is Ozempic. It contains semaglutide, which is used to treat type 2 diabetes. However, the drug has also proven effective for weight loss.

Even though the drug is available only by prescription, it is increasingly being counterfeited. According to WHO, Ozempic counterfeits have already been detected in European countries such as the United Kingdom and Northern Ireland, as well as in the USA and Brazil.

WHO warns

WHO advises healthcare workers, regulatory authorities, and patients to be aware of counterfeit drug batches, emphasized Dr. Yukiko Nakatani, WHO's deputy director-general.

The World Health Organization recommends refraining from using suspicious medications and avoiding purchasing drugs from unknown or unverified sources, such as the Internet.

The organization notes that counterfeit drugs can hurt health. Counterfeit products may contain insufficient amounts of the active substance or include incorrect ingredients like insulin.

Semaglutide is prescribed to individuals with type 2 diabetes. The substance aims to lower blood sugar levels and additionally reduces the risk of cardiovascular events.

Products containing this substance also suppress appetite, which is why they are prescribed for weight reduction in some countries. Due to their high cost, preparations based on semaglutide are not included in the range of drugs recommended by WHO for the treatment of diabetes.

Related content
© essanews.com
·

Downloading, reproduction, storage, or any other use of content available on this website—regardless of its nature and form of expression (in particular, but not limited to verbal, verbal-musical, musical, audiovisual, audio, textual, graphic, and the data and information contained therein, databases and the data contained therein) and its form (e.g., literary, journalistic, scientific, cartographic, computer programs, visual arts, photographic)—requires prior and explicit consent from Wirtualna Polska Media Spółka Akcyjna, headquartered in Warsaw, the owner of this website, regardless of the method of exploration and the technique used (manual or automated, including the use of machine learning or artificial intelligence programs). The above restriction does not apply solely to facilitate their search by internet search engines and uses within contractual relations or permitted use as specified by applicable law.Detailed information regarding this notice can be found  here.